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The purpose of the present case report was to describe the surgical treatment of a peri-implantitis lesion associated with a
regenerative approach. A 48-year-old patient came to authors’ attention 36 months after the placement of a dental implant (ITI-
Bonefit Straumann, Waldenburg, Switzerland) in position 46. A swelling of the peri-implant soft tissues was observed, associated
with bleeding on probing and probing depth > 10mm. A significant peri-implant bone loss was clearly visible on the periapical
radiograph. A nonsurgical periodontal supportive therapy was firstly conducted to reduce the inflammation, followed by the
surgical treatment of the defect. Aftermechanical and chemical decontaminationwith tetracycline solution, a regenerative approach
consisting in the application of deproteinized bovine bone mineral (Bio-Oss, Geistlich Pharma AG, Wolhusen, Switzerland) and a
collagenmembrane (Bio-Gide, Geistlich PharmaAG,Wolhusen, Switzerland) was performed. An antibiotic therapy was associated
with the treatment.The 17-year follow-up showed a physiological probing depth with no clinical signs of peri-implant inflammation
and bleeding on probing. No further radiographic bone loss was observed. The treatment described in the present case report
seemed to show improved clinical results up to a relevant follow-up period.
1. Introduction
While peri-implant mucositis describes a reversible inflam-
matory lesion limited to the mucosa, peri-implantitis also
affects the supporting bone circumferentially around an
osseointegrated dental implant [1]. However, although these
definitions are universally accepted, the diagnostic criteria
still raise doubts. The critical parameter in the diagnosis
of peri-implant mucositis is bleeding on gentle probing
(<0.25N). Peri-implantitis lesions are characterized by irre-
versible changes in the crestal bone levels in conjunction
with bleeding on probing (BOP)with orwithout concomitant
worsening of peri-implant pockets. Furthermore, suppura-
tion is a common finding in peri-implant affected sites [2].
Peri-implant disease recognises a bacterial etiopatho-
genesis. The microbiota associated with peri-implant soft
tissues has been identified in many cross-sectional studies.
Particularly, it has been proved that gram-positive facultative
cocci and rods represent the dominating bacterial compo-
sition [3–5]. However, gram-negative anaerobic rods may
also be found in small numbers and in low proportions. An
endoscopic clinical study by Wilson Jr. demonstrated that
even the presence of submucosal dental cement could have
a positive relationship with peri-implantitis, as the foreign
body gives rise to a bacterial infection [6]. With respect to
the etiopathogenesis of implant failures, also nonmicrobial
events have to be taken into account, including implant
fractures as a consequence of occlusal overloading [7, 8].
As in cases of periodontitis, peri-implant infections
may take years to develop. It could be assumed that the
susceptibility to periodontal disease may be translated into
predisposition to peri-implantitis. Accordingly, longitudi-
nal studies have investigated the transmission of putative
periodontal pathogens from periodontal to implant sites [3,
9, 10]. These findings stress the importance of eliminating
potential reservoirs of periodontal pathogens before implant
placement maintaining at the same time a periodontal health
status in partially dentate patients with oral implants.
Several detoxification procedures have been proposed
to decontaminate peri-implantitis affected implant surfaces,
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Figure 1: Clinical situation of the peri-implantitis affected implant,
before treatment procedures. A mesial PD of 11mm and a distal PD
of 12mm were recorded.
including air-powder abrasion, saline wash, citric-acid appli-
cation, laser therapy, peroxide treatment, ultrasonic/manual
debridement, and application of topical medication; however
a definite gold standard could not be identified [11].
In case of a surgical approach, the primary purpose is
to obtain access for debridement and decontamination of
the infected implant surface. Furthermore, the apposition
of bone substitutes might be recommended when the type
of bone defect is suitable for a regenerative procedure; a
well-defined crater-like defect may improve retention of the
bone graft thereby allowing for an optimal healing [12].
Regenerative surgical therapy associated with the use of
autogenous bone graft has demonstrated positive results up to
3 years [13]. Studies employing combinations of bone grafts,
bone substitutes, and membranes have reported clinical and
radiographic improvements over 3 to 4 years [14–16].
The purpose of the present case report was to show the
long-term outcome of a surgical peri-implantitis treatment
associated with regenerative procedures, focusing on the
importance of both implant surface decontamination by
means of tetracycline applications and reconstructive therapy
with particulate heterologous bone graft.
2. Case Report
A 48-year-old female patient in good general health, with no
local or systemic contraindications to oral surgery, without
known allergies or sensitivities to medications, came to
authors’ observation in 1997. The patient showed swelling of
the peri-implant soft tissues, associated with BOP and prob-
ing depth (PD) > 10mm around an ITI-Bonefit (Straumann,
Waldenburg, Switzerland) implant (4.1mm in diameter and
12mm in length), placed three years earlier in position 46
(Figure 1). The defect consisted in a circumferential bone
resorption associated with a buccal dehiscence under main-
tenance of the lingual cortical plate, according to Class Ic
(Schwarz et al. defect classification [12]). No clinical signs
of mobility were recorded; however the periapical radio-
graph revealed a radiolucent area delimitating the implant
(Figure 2).
Once peri-implantitis was diagnosed, a nonsurgical peri-
odontal supportive therapy was firstly performed to reduce
the inflammation, followed by the surgical treatment of
Figure 2: Preoperative intraoral radiography. A typical peri-
implantitis crater-like defect was evident.
Figure 3: Clinical situation after the elevation of a mucoperiosteal
flap. Granulation tissue delimitating the peri-implantitis defect was
clearly visible around the implant.
the defect. The latter consisted in the elevation of a full-
thickness flap to have access to the bone defect and to
mechanically remove the granulation inflammatory tissue
around the implant (Figures 3 and 4). The mechanical
decontamination was performed with Teflon curettes to
minimise possible damages to the fixture surface. Concerning
the chemical treatment, a 50mg/mL tetracycline solutionwas
topically applied with cotton pledged for 2 minutes on the
exposed threads and was then rinsed off with physiological
saline sterile irrigation. The bone defect was then grafted
with deproteinized bovine bone mineral (DBBM) (Bio-Oss,
Geistlich Pharma AG, Wolhusen, Switzerland) (Figure 5)
and a resorbable collagen membrane (Bio-Gide, Geistlich
Pharma AG, Wolhusen, Switzerland) was placed to protect
the graft from the surrounding soft tissue cells penetration
(Figure 6). Nylon 5/0 single stitches were applied to permit
a primary intention wound healing. The implant remained
without the prosthetic crown during the 6-month healing
period. The healing abutment was not placed because of the
high neck design of the transmucosal implant. Antibiotic
therapy consisting in amoxicillin 500mg three times a day
was administrated during the following 7 days, associated
with chlorhexidine 0,2% mouth rinses starting from the day
after the surgery and extended to the next twoweeks, in order
to prevent postsurgical secondary infections. The sutures
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Figure 4: Clinical situation after the careful removal of the granu-
lation tissue.The typical crater-like peri-implantitis bone defect was
present circumferentially around the implant.
Figure 5: The bone defect was packed with heterologous DBBM
graft.
were removed 12 days after the surgery. Neither swelling nor
pain occurred during the healing period. After 6 months
the crown was replaced and an intraoral radiography was
taken, showing increased radiopacity and complete filling
of the defect with newly formed mineralized bone around
the implant (Figure 7). The PD measurement was 1mm and
neither BOP nor mobility of the implant was recorded.
The patient underwent regular professional oral hygiene
procedures every 6 months and a recall visit was conducted
at least once a year. During the follow-up visit after 17 years,
the implant was still supporting a fixed prosthetic crown.
The peri-implant soft tissues presented no clinical signs of
inflammation and BOP, and a physiological PD of 1.5mm
was measured (Figure 8). The mesial and distal levels of the
peri-implant marginal bone were radiographically stable as
demonstrated by the follow-up periapical X-rays (Figure 9).
Figure 6: A bioabsorbable collagen membrane was placed in order
to create a secluded space over the DBBM graft.
Figure 7: Postoperative intraoral radiography. The graft filled into
the bone defect was observable in close contact with the implant
surfaces. During the healing period the implant was left unloaded.
3. Discussion
Several surgical procedures for the treatment of peri-
implantitis could be found in literature. Nonsurgical ther-
apy might be effective in the treatment of peri-implant
mucositis. Furthermore, the adjunctive use of antimicrobial
mouth rinses may enhance the outcome of the mechanical
debridement in case of peri-mucositis. In peri-implantitis
lesions however, nonsurgical therapy was found to be less
effective. For this reason, surgical therapy and adjunctive
local or systemic antibiotics may cooperate in the reduction
of BOP and PD parameters [17]. Attempts have been made to
determine the optimal conservative, regenerative, or resective
surgical protocol to achieve the complete resolution of peri-
implantitis, including the regeneration of lost tissues and
the hypothetical reestablishment of osseointegration along
previously contaminated implant surfaces, as described in
the present case report. In these terms, bone defect con-
figuration seems to play a key role concerning the clinical
outcome following a surgical regenerative approach of peri-
implantitis lesions, as suggested by Schwarz et al. [12]. Defects
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Figure 8: Clinical situation during the follow-up recall. Peri-
implant soft tissues appeared healthy, with no sign of inflammation
and suppuration.
Figure 9: 17-year follow-up intraoral radiography.The peri-implant
marginal bone levels appeared radiographically stable, without any
sign of bone resorption mesially and distally to the implant.
characterized by a deep vertical component with the buccal
and lingual bone plates preserved have a more predictable
outcome following regenerative therapy, as confirmed by the
present case.
In this report, topical application of tetracycline solu-
tion for implant surface decontamination has proven to
be an effective treatment option when coupled with bone
regenerative procedures, as demonstrated by the long-term
follow-up. Tetracyclines are broad-spectrum agents, exhibit-
ing activity against a wide range of gram-positive and gram-
negative bacteria, inhibiting protein synthesis by preventing
the attachment of aminoacyl-tRNA to the ribosomal acceptor
(A) site. The favourable antimicrobial properties of these
agents and the absence of major adverse side effects have led
to their extensive use in the therapy of human infections [18].
On the other hand, it was demonstrated that the development
of resistance mechanisms may reduce the effectiveness of
the molecule [19]. Even if tetracyclines in dentistry can
be administrated systemically, recent trials indicated that
locally delivered antimicrobials might enhance the effects of
periodontal surgical therapy and reduce the signs of peri-
implantitis [20].The topical use in previously infected natural
pockets has to be preferred, in order to reduce the probability
of exogenous reinfection during the healing period [21].
Tetracyclines are released at effective concentrations over
7 days, and significant reductions in anaerobic pathogens
up to 60% could be sustained for 6 months posttreatment
[22]. Tetracycline fibers were originally applied topically
in the treatment of periodontal diseases: affected sites had
fibers placed to the depth of periodontal pockets, maintained
in place by superficial applying of cyanoacrylate adhesive.
Subsequently, the local use of tetracycline showed positive
effects on clinical and microbiological parameters in the
treatment of peri-implantitis [23]. Actually, this class of
antibiotic showed improved clinical results when involved in
the treatment of peri-implantitis in conjunction with bone
grafts filled into the defect [24].
The choice of the graftmaterial deserves somewords to be
spent. A wide selection has been used over the years for the
treatment of peri-implantitis.Themajority of peri-implantitis
cases found in literature and treated with graft materials
alone were located in the mandible. Although some failures
were reported, most of the treatments generally resulted
in improved clinical results. The studies by Behneke et al.
included multiple defects approached by means of autoge-
nous bone grafts with observation intervals extending for
some cases up to 3 years [13, 25, 26]. Notable reductions of PD
coupled with significant radiographic bone fill were reported.
Out of the 25 consecutive lesions treated, failure and graft
removal was reported only for two lesions. Other four lesions
showed flap dehiscences within 2-3 weeks after grafting,
which healed following chlorhexidine rinses or osteoplasty
[13]. Guided bone regeneration may constitute a predictable
way to treat osseous peri-implant defects improving soft
tissues condition as well. Most of the studies concerning the
treatment of peri-implantitis comprehended those in which a
combination of grafts and barrier membranes was used. The
submerged approachwas used in half of these studies to allow
for undisturbed healing and to reduce the risk of infection.
From the results it was evident that the submerged approach
was not always successful in practice, as the most common
complication was the membrane exposure. A comparative
study published by Khoury and Buchmann evaluated the
use of autogenous bone grafts alone or associated with both
bioabsorbable andnonresorbablemembranes in a submerged
approach. The results showed no significant differences
between the groups in terms of treatment outcome after
3 years; however complications quite often occurred when
membranes were used [14]. A study by Schwarz et al. eval-
uated the healing of intrabony peri-implant defects following
application of a nanocrystalline hydroxyapatite paste or
DBBM in combination with resorbable collagen membranes.
Clinical parameters were recorded at baseline and after 6
months. Results showed that both treatments led to improved
clinical conditions [27]. Recently, a study by Roos-Jansa˚ker et
al. compared two surgical techniques using a bone substitute
with or without the application of bioabsorbable membranes
adopting a nonsubmerged approach. According to Khoury et
al. no significant differences were observed between either
group [14, 15]. It could be concluded that the placement of
membranes in addition to bone grafting does not provide
any adjunctive effect. Considering the present case report,
at the time of intervention much of this knowledge was still
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unknown; however it could be assumed that the presence of
a bioabsorbable membrane may have promoted an undis-
turbed graft remodelling, permitting a new bone formation
due to the creation of a secluded space over the graft against
the ingrowth of soft tissue cells surrounding the defect.
Moreover, differently from nonresorbable membranes, the
bioabsorbable collagenmembrane used in the present clinical
case may have decreased the risk of membrane exposure,
allowing an uneventful healing as demonstrated by the 6-
month recall visit.
Peri-implant disease treatment is still a controversial
topic, as several authors provided different therapeutic solu-
tions [28]. A correct diagnosis represents the first and most
important step in order to schedule an adequate treatment
and its relevance is univocally acknowledged. In 2004 Lang
et al. published important guidelines based on a diagnostic-
therapeutic algorithm [29]. In presence of a severe level of
the disease, in addition to the implant surface decontami-
nation and antibiotic therapy, a surgical approach should be
performed. When regenerative treatment is chosen, the use
of a barrier membrane technique, even in combination with
bone substitutes like DBBM, is recommended.
4. Conclusion
The results obtained in the present report stressed the impor-
tance of a combined antibiotic andmechanical decontamina-
tion associatedwith a regenerative procedure in the treatment
of seriously compromised implants. This treatment led to
positive effects on the clinical and radiological parameters
over a long-term follow-up timespan.
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